Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 12 > >>
EC Number Crystallization (Commentary)
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.261.75 A X-ray crystal structure of the enzyme complexed with O-methyl-L-tyrosine and a non-hydrolyzable ATP analogue
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26apo-PylRS and PylRS complexes with different ligands, X-ray diffraction structure determination and analysis
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26crystal structure of PylRS apoenzyme and in complex with tRNAPy, to 2.5 and 3.1 A resolution, respectively. The protein forms a dimer in the crystal and in solution
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26crystal structures of a catalytic fragment of the enzyme complexed with N3-(tert-butyloxycarbonyl)-L-lysine and an ATP analog and with Nepsilon-allyloxycarbonyl-L-lysine reveals that the enzyme requires an Nepsilon-carbonyl group bearing a substituent with a certain size
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26crystal structures of the PylRS catalytic fragment in the substrate-free, ATP analogue (AMPPNP)-bound, and AMPPNP/pyrrolysine-bound forms, compared with other PylRS structures
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26efforts to crystalize full-length PylRS are not successful due to the low solubility of the protein. The N-terminal domain is highly insoluble and aggregates full-length PylRS. But using the truncated C-terminal catalytic core of PylRS from Methanosarcina mazei, apo-PylRS and PylRS complexes with different ligands are successfully determined
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26hanging-drop vapour-diffusion method at 21°C, the triclinic form crystals contain two PylRS dimers (four monomer molecules) in the asymmetric unit, in which the two subunits in one dimer each bind Nepsilon-(tert-butyloxycarbonyl)-L-lysyladenylate and the two subunits in the other dimer each bind AMP
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26mutant Y384F/A302T/N346V/C348W/V401L in complex with O-methyl-L-tyrosine, hanging drop vapor diffusion method, using
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26purified recombinant His-tagged N-terminally truncated enzyme form PylRS(c270) in complex with an ATP analogue AMP-PNP, hanging drop vapour diffusion method, in 100 mM sodium cacodylate, pH 6.8, containing 0.25 M NaCl, 5 mM MgSO4 and 5% w/v PEG 4000, 20°C, hexagonal crystals, X-ray diffraction structure determination and analysis at 1.9-2.6 A resolution
Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.26purified recombinant N-terminally His-tagged catalytic domain of PylRS complexed with either AMP-PNP, pyrrolysine-AMP plus pyrophosphate, or the pyrrolysine analogue N-epsilon-[(cylopentyloxy)carbonyl]-L-lysine plus ATP, vapour diffusion method, 10 mg/ml protein in 100 mM Tris, pH 7.0-8.0, 8-14% PEG 2000 monomethyl ether, 10 mM pyrrolysine, and10 mM AMP-PNP or other ligands, overnight at 16°C, stabilization and cryoprotection by 5 mM EDTA, 10 mM AMP-PNP, 5 mM MgCl2, 30% ethylen glycol, and additional 2% PEG, hexagonal-shaped crystals, X-ray diffraction structure determination and analysis at 1.8 A resolution
Results 1 - 10 of 12 > >>